RoslinCT is a contract manufacturing organisation focused on providing tailored process development services and robust GMP manufacturing solutions for companies developing cell-based therapeutics for clinical trials.
Supporting you at every step of your advanced therapy journey.
25 June 2020
RoslinCT - a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) - announces initiation of construction for the expansion of their new manufacturing centre. This expansion accelerates our development and manufacturing capability, promising to bring next-generation treatments to patients globally.
26 March 2019
RoslinCT is a leading Contract Development and Manufacturing Organisation (CDMO), offering a range of integrated services from technology transfer, process and assay development through to GMP manufacturing, storage, QP certification and batch release of cell-based therapies for clinical trials.
22 March 2019
RoslinCT, a leading cell and gene therapy contract manufacturing organisation, is pleased to announce the appointment of David Bowie to the Board of Directors. David has over twenty-eight years of international sales, marketing management and business development experience in the global healthcare sector which led him to the board of the Scottish Government backed Life Science Scotland Industry Leadership Group for some 12 years. David brings a wealth of life science industry experience, locally and globally, to the position.
04:09 pm Jan 20th
10:01 am Dec 24th
From all of us at RoslinCT, we wish you and your loved ones health, happiness and prosperity this festive season an… https://t.co/VVUXFThzDP
12:21 pm Dec 21st
We are very proud and excited to announce that the Department for Business, Energy and Industrial Strategy (BEIS) a… https://t.co/jtu5lDoKv8